openPR Logo
Press release

Global Dendritic Cell Cancer Vaccine Market Outlook 2020 Report

05-07-2018 08:52 AM CET | Health & Medicine

Press release from: Kuick Resarch

Global Dendritic Cell Cancer Vaccine Market Outlook 2020 Report

“Global Dendritic Cell Cancer Vaccine Market Outlook 2020” Report highlights:

* Introduction & Mechanism of Action of Dendritic Cells
* New Vaccine Strategies That Exploit Dendritic Cells Biochemistry
* Dendritic Cell Cancer Vaccine Market & Clinical Insight
* Comparative Insight of Dendritic Cell Vaccines & Other Class of Vaccines
* Dendritic Cell Cancer Vaccine Pipeline by Country, Company, Indication & Phase
* Dendritic Cell Cancer Vaccine Clinical Pipeline: 58 Vaccines
* Majority in Phase I/II & Phase II Clinical Trials: 12 Vaccines

Download Report Sample Weblink:

https://www.kuickresearch.com/report-Global-Dendritic-Cell-Cancer-Vaccine-Market-Outlook-2020.php

For Report Sample Contact: neeraj@kuickresearch.com

Table of Contents

1. Dendritic Cells Cancer Vaccine: The Genesis



2. Classification of Dendritic Cells



3. Mechanism of Action of Dendritic Cells

3.1 Antigen Presentation & Induction of Cellular Immune Responses

3.2 Sources of Antigen to Be Loaded Onto Dendritic Cells

3.3 Dendritic Cells Source & Subsets

3.4 Maturational State

3.5 Maturation Stimuli

3.6 Migration

3.7 Route, Dose & Schedule of Dendritic Cells Vaccination

3.8 Clinical Results in Miscellaneous Cancers

3.9 Quality Control

3.10 Immune Monitoring



4. New Vaccine Strategies That Exploit Dendritic Cells Biochemistry

4.1 Provision of CD4 T-Cell Help for CD8 T Cells

4.2 Strategies to Recruit, Mature & Load Dendritic Cells In Situ

4.3 Strategies to Activate NKT Cells



5. Dendritic Cell Cancer Vaccine Market & Clinical Insight

5.1 Some Trends Involving Dendritic Cells Cancer Vaccination

5.2 Dendritic Cell Cancer Vaccine Pipeline Overview



6. A Comparative Insight of Dendritic Cell Vaccines & its Peers

6.1 Dendritic Cell Cancer Vaccine & Monoclonal Antibodies

6.2 Dendritic Cell Cancer Vaccine & Peptide Based Cancer Vaccine

6.3 Dendritic Cell Cancer Vaccine & Cytokine Based Cancer Vaccine

6.4 Dendritic Cell Cancer Vaccine & Antibody Drug Conjugate Based Cancer Vaccine



7. The Growth Factors: Why the Fixation with Dendritic Cell Cancer Vaccines?



8. Road Ahead: Dendritic Cell Cancer Vaccine in the Challenging Horizon of Cancer Immunotherapy



9. Conclusion: Dendritic Cell Cancer Vaccine; a Silver Lining to the Dark Under-Belly of Cancer



10. Dendritic Cell Cancer Vaccine Clinical Pipeline By Country, Company, Indication & Phase

10.1 Research

10.2 Preclinical

10.3 Clinical

10.4 Phase-I

10.5 Phase-I/II

10.6 Phase-II

10.7 Phase-II/III

10.8 Phase-III



11. Marketed Dendritic Cell Cancer Vaccine: CreaVax® ( Renal Cancer, South Korea)



12. Market Withdrawl: Provenge by Dendreon Corporation



13. Discontinued & Suspended Dendritic Cell Cancer Vaccine in Clinical Trials

13.1 Discontinued

13.2 No Development Reported

13.3 Suspended



14. Competitve Landscape

14.1 3M Company

14.2 Activartis

14.3 Argos Therapeutics

14.4 Batavia Bioservices

14.5 Bellicum Pharmaceuticals

14.6 Creagene

14.7 DanDrit Biotech

14.8 DCPrime

14.9 Dendreon Corporation

14.10 Elios Therapeutics

14.11 ImmunoCellular Therapeutics

14.12 Immunicum

14.13 Kiromic

14.14 Medigene

14.15 Merck

14.16 Northwest Biotherapeutics

14.17 Glaxo Smith Kline

14.18 ImmunoCellular Therapeutics

14.19 SOTIO

14.20 Tella Incorporation

14.21 Theravectys

14.22 Vaxil BioTherapeutics

Figure 1-1: Advantages of Dendritic Cell Cancer Vaccine

Figure 2-1: Classification of Dendritic Cells

Figure 3-1: Principle of Dendritic Cell Cancer Immunotherapy

Figure 3-2: The Key Players Intricately Involved in Antigen Presentation & Immune Response Machinery

Figure 3-3: Process of Antigen-loading

Figure 3-4: Major Life Cycle Events of a Dendritic Cell

Figure 3-5: A Diagrammatic Representation of Dendritic Cell Plasticity

Figure 3-6: Action of Dendritic Cells on the Various Cancer Forms

Figure 4-1: The Arsenals in the Inventory of Dendritic Cells

Figure 5-1: Recent Trends in Dendritic Cell Vaccine

Figure 5-2: Dendritic Cell Cancer Vaccine by Phase (%), 2016

Figure 5-3: Dendritic Cell Cancer Vaccine by Phase (Numbers), 2016

Figure 6-1: Working Principle Targeted By Dendritic Cells & Monoclonal Antibodies

Figure 6-2: Working Principle Targeted by Dendritic Cells & Peptide Cancer Vaccines

Figure 6-3: Working Principle Targeted by Dendritic Cells & Cytokine Cancer Vaccine

Figure 6-4: Working Principle Targeted By Dendritic Cells & Antibody-Drug Conjugates Cancer Vaccines

Figure 7-1: Factors Driving Dendritic Cell Cancer Vaccine

Figure 8-1: Challenges for Dendritic Cell Cancer Vaccine

Figure 14-1: Argos Therapeutics- Clinical Pipeline

Figure 14-2: Bellicum Pharmaceuticals Clinical Pipeline

Figure 14-3: DCPrime Clinical Pipeline

Figure 14-4: ImmunoCellular Therapeutics Clinical Pipeline

Figure 14-5: Immunicum Clinical Pipeline

Figure 14-6: Medigene Clinical Pipeline

Figure 14-7: Northwest Biotherapeutics Clinical Pipeline

Figure 14-8: SOTIO Clinical Pipeline

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Dendritic Cell Cancer Vaccine Market Outlook 2020 Report here

News-ID: 1040957 • Views: 246

More Releases from Kuick Resarch

Global Cell Therapy Market To Surpass US$ 35 Billion By 2026
Global cell therapy market is expected to surpass US$ 35 Billion by 2026 as per recent report “Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026” published by Kuick Research. Increasing investment, gaining research and development activities along with new technological advancement will drive the global cell therapy market. Download Report: https://www.kuickresearch.com/report-global-cell-therapy-market,-clinical-trials,-therapy-price-and-opportunity-insight-2026.php “Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026” Report Highlights: • Global Cell Therapy
Cell Therapy Market Size Growth Cell Therapy Clinical Trials Market Forecast 202 …
Cell therapies are still in the infancy stages of the clinical development and are expected to evolve in the market with a vast number of opportunities in the healthcare industry. In order to form a stable base for process evaluation and development it will be essential to understand the quality of cell based products. With an increasing number of cell therapies and clinical indications being assessed, it is clear that
Global Cell Therapy Market Size Analysis Clinical Trials Growth Forecast 2026
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
CAR T Cell Therapy Changing The Cancer Oncology Drug Market Landscape
" Global CAR T Cell Therapy Market & Clinical Trials Insight 2024" Report Highlights: • CAR T-Cell Therapies Delivery Pipeline & Mechanism of Action • Sales Analysis of CAR - T Cell Therapy • CAR - T Cell Therapy Market Opportunity: US$ 700 Million • CAR-T Cell Therapies Clinical Pipeline by Company, Indication & Phase: 236 Therapies • CAR-T Cell Therapies in Highest Phase: Preclinical • Marketed CAR-T Cell Therapies: 2 ( Yescarta & Kymriah) • Global Market Scenario of

All 5 Releases


More Releases for Cell

Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Therapy Market Cell Therapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Cell Therapy Necessity for Cell Therapy Treatment 2.1 Emergence of Stem Cell Research 2.2 Benefits of Using the Stem Cell for Research and Treatment Application of Stem Cells in Cell Therapy 3.1 Stem Cells Ability to Differentiate 3.1.1 Totipotent Stem Cells 3.1.2 Pluripotent Stem Cells 3.1.3 Multipotent
Global Cell Therapy Market & Cell Therapy Clinical Pipeline Outlook 2022
The cell therapy industry is rapidly growing industry with the several new products that having been accepted for clinical use over the past few years. There are many challenges that need to be resolved wisely before the cell therapies are widely accepted, including the optimization of their manufacture. There is much to be explored about the specific features of the stem cells and about the efficacy and safety of the
Cell Science 2017
It takes us immense pleasure to announce the conference that “Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine” which is going to be held during November 29-30, 2017 at Atlanta, USA. Cell Science 2017 conference will focus on the latest and exciting innovations in all areas of Cell Biologists and Stem Cell Researchers which offer a unique opportunity for investigators across the globe to meet, network, and perceive
Cell Science 2017
Pulsus Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity.With a legacy of 30 years of excellence in Medical Publishing we are endorsed by various societies like International Academy of Cardiovascular Sciences, International Society of Addiction Medicine, European Biotechnology Thematic Network Association, World Federation of